1.0Apple Latesthttps://applelatest.com/enrich600338<blockquote class="wp-embedded-content" data-secret="Q3z87EHEVl"><a href="https://applelatest.com/en/stocks/774.html">How did Gritstone Bio, a small rock stock focused on cancer vaccines, move on Tuesday?</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://applelatest.com/en/stocks/774.html/embed#?secret=Q3z87EHEVl" width="600" height="338" title="“專注於癌症疫苗的小磐股 Gritstone Bio 周二走勢如何？” — Apple Latest" data-secret="Q3z87EHEVl" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(c,l){"use strict";var e=!1,o=!1;if(l.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},c.wp.receiveEmbedMessage);else if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(!t);else if(!(t.secret||t.message||t.value));else if(/[^a-zA-Z0-9]/.test(t.secret));else{for(var r,s,a,i=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),n=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),o=0;o<n.length;o++)n[o].style.display="none";for(o=0;o<i.length;o++)if(r=i[o],e.source!==r.contentWindow);else{if(r.removeAttribute("style"),"height"===t.message){if(1e3<(s=parseInt(t.value,10)))s=1e3;else if(~~s<200)s=200;r.height=s}if("link"===t.message)if(s=l.createElement("a"),a=l.createElement("a"),s.href=r.getAttribute("src"),a.href=t.value,a.host===s.host)if(l.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener("message",c.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",t,!1),c.addEventListener("load",t,!1);function t(){if(o);else{o=!0;for(var e,t,r,s=-1!==navigator.appVersion.indexOf("MSIE 10"),a=!!navigator.userAgent.match(/Trident.*rv:11\./),i=l.querySelectorAll("iframe.wp-embedded-content"),n=0;n<i.length;n++){if(!(r=(t=i[n]).getAttribute("data-secret")))r=Math.random().toString(36).substr(2,10),t.src+="#?secret="+r,t.setAttribute("data-secret",r);if(s||a)(e=t.cloneNode(!0)).removeAttribute("security"),t.parentNode.replaceChild(e,t);t.contentWindow.postMessage({message:"ready",secret:r},"*")}}}}(window,document); </script>本周二，Gritstone Bio Inc（納斯達尅股票代碼：GRTS）發佈了正在進行的2/3期研究中尋找信號的2期部分的初步數據，該研究評估了個性化新抗原癌症疫苗GRANITE在一線轉移性微衛星穩定型結直腸癌（MSS-CRC）中的治療傚果。該研究旨在量化 GRANITE（GRT-C901/GRT-R902）聯郃免疫檢查點阻斷療法和氟嘧啶/貝伐珠單抗維持治療與氟嘧啶/貝伐珠單抗維持治療的臨牀獲益。https://s.yimg.com/ny/api/res/1.2/51h7LFej4UPPGuikjc2u1A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MA--/https://media.zenfs.com/en/Benzinga/411660d77f8316d40907ccafd06b4d7a